Medpace Holdings Inc (MEDP)
Medpace Holdings Inc is a NASDAQ-listed common stock of a healthcare company that provides clinical research and development services for drug and medical device programs. Its work spans the clinical development process, including study design, project oversight, regulatory support, monitoring, data handling, and safety reporting. The company also provides laboratory and trial support services such as bioanalytical testing, clinical pharmacology, imaging, and ECG reading. Medpace serves pharmaceutical, biotechnology, and medical device clients across North America, Europe, Asia, South America, Africa, and Australia. Founded in 1992 and based in Cincinnati, Ohio, the company supports clinical trials from early-stage development through post-marketing activities.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MEDP
|
$529.17
|
-13.6% Downside
|
Fair
|
$581.83
|
-5.0% Downside
|
Fair
|
Great
|
0.0%
|
October 26, 2026
|
34.9x
|
39.6x
|
6.2x
|
17.091 B
|
16.812 B
|
0.8%
|
80.5%
|
8.9
|
143.8%
|
